Related references
Note: Only part of the references are listed.Facile synthesis of novel fluorescent thiazole coumarinyl compounds: Electrochemical, time resolve fluorescence, and solvatochromic study
Rabail Ujan et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity
Siffeen Zehra et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Substituted phenyl[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetates/acetamides as alkaline phosphatase inhibitors: Synthesis, computational studies, enzyme inhibitory kinetics and DNA binding studies
Zafar Iqbal et al.
BIOORGANIC CHEMISTRY (2019)
DNA binding interaction studies of flavonoid complexes of Cu(II) and Fe(II) and determination of their chemotherapeutic potential
Erum Jabeen et al.
INORGANICA CHIMICA ACTA (2019)
Synthesis, carbonic anhydrase inhibitory activity and antioxidant activity of some 1,3-oxazine derivatives
Rabia Qamar et al.
DRUG DEVELOPMENT RESEARCH (2018)
Electrochemical, spectroscopic and theoretical monitoring of anthracyclines' interactions with DNA and ascorbic acid by adopting two routes: Cancer cell line studies
Fouzia Perveen et al.
PLOS ONE (2018)
Substituted (E)-2-(2-benzylidenehydrazinyl)-4-methylthiazole-5-carboxylates as dual inhibitors of 15-lipoxygenase & carbonic anhydrase II: synthesis, biochemical evaluation and docking studies
Aamer Saeed et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111
Carrie L. Lomelino et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines
Nagwa M. Abdel Gawad et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors
Junyuan Tang et al.
BIOORGANIC CHEMISTRY (2016)
Troxerutin, a natural flavonoid binds to DNA minor groove and enhances cancer cell killing in response to radiation
Niranjan A. Panat et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Synthesis, kinetic mechanism and docking studies of vanillin derivatives as inhibitors of mushroom tyrosinase
Zaman Ashraf et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase
Zaman Ashraf et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors
Zaman Ashraf et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Synthesis, Spectroscopy, Semi-empirical and Biological Activities of Organotin(IV) Complexes with o-Isopropyl Carbonodithioic Acid
Fatima Javed et al.
JOURNAL OF THE CHINESE CHEMICAL SOCIETY (2015)
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies
Murat Bozdag et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
β-Cyclodextrin assisted solubilization of Cu and Cr complexes of flavonoids in aqueous medium: A DNA-interaction study
Erum Jabeen et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2014)
Drug-DNA interactions and their study by UV-Visible, fluorescence spectroscopies and cyclic voltametry
Muhammad Sirajuddin et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2013)
Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases
Jean-Yves Winum et al.
CHEMICAL COMMUNICATIONS (2012)
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
Vincenzo Alterio et al.
CHEMICAL REVIEWS (2012)
Discovery of new chromone containing sulfonamides as potent inhibitors of bovine cytosolic carbonic anhydrase
Mariya al-Rashida et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
Fabio Pacchiano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Carbonic anhydrase inhibitors
Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Sulfonamide Linked Neoglycoconjugates-A New Class of Inhibitors for Cancer-Associated Carbonic Anhydrases
Marie Lopez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding
Vijay M. Krishnamurthy et al.
CHEMICAL REVIEWS (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors
Ludwig Dubois et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours
Antti J. Kivela et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects
S Pastorekova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2004)
Anticancer and antiviral sulfonamides
A Scozzafava et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Carbonic anhydrase inhibitors
CT Supuran et al.
MEDICINAL RESEARCH REVIEWS (2003)
Applications of carbonic anhydrase inhibitors and activators in therapy
CT Supuran et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2002)
Novel sulphonamide derivatives for the treatment of cancer
T Owa et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2000)